Abid Mehmood Yousaf,1 Dong Wuk Kim,1 Yu-Kyoung Oh,2 Chul Soon Yong,3 Jong Oh Kim,3 Han-Gon Choi11College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, 2College of Pharmacy, Seoul National University, Seoul, 3College of Pharmacy, Yeungnam University, Gyongsan, South KoreaBackground: The intention of this research was to prepare and compare various solubility-enhancing nanoparticulated systems in order to select a nanoparticulated formulation with the most improved oral bioavailability of poorly water-soluble fenofibrate.Methods: The most appropriate excipients for different nanoparticulated preparations were selected by determining the drug solubility in 1% (w/v) aqueous solutions of each carr...
Potensi formulasi berasaskan sebaran pepejal menggunapakai Gelucire 44/14 sebagai pembawa untuk men...
Low dissolution rate of a poorly water soluble drug often leads to low and variable oral bioavailabi...
The present study An antilipemic agent, fenofibrate decreases the levels of fatty substances in the ...
This study aimed to evaluate the effect of biocompatible polymers on the physicochemical and dissolu...
The objective of this study is to explore the influence of polyvinylpyrrolidone (PVP) quantity on th...
A novel free-flowing fenofibrate-loaded gelatin microcapsule formulation was prepared using ethanol ...
An increasing number of newly developed drugs show bioavailability problems due to poor water solubi...
A novel solid particle system with a nanomatrix structure and without surfactant for the oral delive...
Nanoemulsions (NMs) are one of the most important colloidal dispersion systems that are primarily us...
Purpose: The purpose of the present research was to develop a novel electrosprayed nanospherule prov...
The aim of present research work was to formulate and evaluate nanosuspension of fenofibrate which i...
The aim of the present study was to make a fenofibrate (FNB) nanocrystal (NC) by wet media milling, ...
The aim of this study is to investigate the potential of nanostructured lipid carriers (NLCs) in imp...
Objective: The aim of the present study was to investigate the effect of novel polymeric carriers an...
Kazi Mohsin,1 Rayan Alamri,1 Ajaz Ahmad,2 Mohammad Raish,3 Fars K Alanazi,1 Muhammad Delwar Hussain4...
Potensi formulasi berasaskan sebaran pepejal menggunapakai Gelucire 44/14 sebagai pembawa untuk men...
Low dissolution rate of a poorly water soluble drug often leads to low and variable oral bioavailabi...
The present study An antilipemic agent, fenofibrate decreases the levels of fatty substances in the ...
This study aimed to evaluate the effect of biocompatible polymers on the physicochemical and dissolu...
The objective of this study is to explore the influence of polyvinylpyrrolidone (PVP) quantity on th...
A novel free-flowing fenofibrate-loaded gelatin microcapsule formulation was prepared using ethanol ...
An increasing number of newly developed drugs show bioavailability problems due to poor water solubi...
A novel solid particle system with a nanomatrix structure and without surfactant for the oral delive...
Nanoemulsions (NMs) are one of the most important colloidal dispersion systems that are primarily us...
Purpose: The purpose of the present research was to develop a novel electrosprayed nanospherule prov...
The aim of present research work was to formulate and evaluate nanosuspension of fenofibrate which i...
The aim of the present study was to make a fenofibrate (FNB) nanocrystal (NC) by wet media milling, ...
The aim of this study is to investigate the potential of nanostructured lipid carriers (NLCs) in imp...
Objective: The aim of the present study was to investigate the effect of novel polymeric carriers an...
Kazi Mohsin,1 Rayan Alamri,1 Ajaz Ahmad,2 Mohammad Raish,3 Fars K Alanazi,1 Muhammad Delwar Hussain4...
Potensi formulasi berasaskan sebaran pepejal menggunapakai Gelucire 44/14 sebagai pembawa untuk men...
Low dissolution rate of a poorly water soluble drug often leads to low and variable oral bioavailabi...
The present study An antilipemic agent, fenofibrate decreases the levels of fatty substances in the ...